Drug Delivery Systems to 2012 - Freedonia Market Research

Drug Delivery Systems to 2012

Drug Delivery Systems to 2012 - Freedonia Market Research
Drug Delivery Systems to 2012
Published Mar 01, 2008
376 pages — Published Mar 01, 2008
Price US$ 4,500.00  |  Buy this Report Now

This report is also available for purchase on a per-page basis.

About This Report

  
Abstract:

US demand for drug delivery systems will grow 10 percent annually through 2012. Oral types will remain the largest drug delivery category while parenteral, inhalation and implantable systems grow the fastest. Parenteral formulations will eventually surpass oral dosages as the largest product group. This study analyzes the $80.2 billion US drug delivery system industry. It presents historical demand data for the years 1997, 2002 and 2007, and forecasts for 2012 and 2017 by material (e.g., sterile and purified water, synthetic polymers, cellulose derivatives, minerals); type (e.g., oral, parenteral, inhalation, transdermal, implantable); and application. The study also considers market environment factors, details industry structure, evaluates company market share and profiles 30 leading industry players, including GlaxoSmithKline, Genentech, AstraZeneca, Abbott Laboratories, Wyeth, Eli Lilly, Johnson & Johnson, Sanofi-Aventis, Amgen, and Pfizer.

  
Source:
Document ID
2294
Country
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
INTRODUCTION13
EXECUTIVE SUMMARY43
MARKET ENVIRONMENT741
General72
Macroeconomic Trends93
Demographic Patterns122
Health Care Trends141
Health Insurance143
Medical Conditions176
National Health Expenditures233
Medical Providers265
Patient Activity314
Pharmaceutical Market Overview352
Regulation371
Research &Development381
Demand Patterns &Forecasts399
DRUG DELIVERY MATERIALS4833
General483
Sterile &Purified Water512
Synthetic Polymers531
Polyethylene Glycol (PEG)542
Acrylic Polymers563
Polyethylene Oxide591
Polyvinyl Alcohol601
Other Synthetic Polymers612
Cellulose Derivatives631
Ethyl Cellulose641
Hydroxypropyl Methylcellulose (HPMC)651
Other Cellulose Derivatives661
Minerals671
Mineral Hydrocarbons682
Other Minerals703
Other Drug Delivery Materials731
Starch Compounds742
Sugars &Polyols763
Natural Gums791
All Other Drug Delivery Materials801
DRUG DELIVERY SYSTEMS OVERVIEW8113
General812
Types of Drug Delivery Systems832
Historical Demand Patterns853
Regulation881
Research &Development891
US Trade902
International Markets922
ORAL DRUG DELIVERY SYSTEMS9430
General943
Controlled-Release Formulations972
Technologies991
Coated Systems1003
Diffusion Systems1033
Reservoir Systems1063
Chewable Tablets1093
Orally Disintegrating Tablets1123
Nanoparticulate Formulations1151
Ethical Pharmaceuticals1163
Over-the-Counter Drugs1192
Transmucosal Formulations1213
PARENTERAL DRUG DELIVERY SYSTEMS12455
General1243
Therapeutic Monoclonal Antibodies1272
Technology1294
Anti-Cancer Agents1336
Other Therapeutic Monoclonal Antibodies1396
Products in Development1452
Prefilled Syringes1472
Applications1491
Injectors1503
Cartridges &Insulin Pens1532
Encapsulated Systems1552
Polymer-Protected Systems1577
Liposomes1643
Developmental Activities1678
Premixed IV Solutions1751
Mini-Bags1761
Bag/Vial Infusion Systems1771
Applications1781
INHALATION, TRANSDERMAL &IMPLANTABLE DRUG DELIVERY SYSTEMS17937
General1793
Inhalation Drug Delivery Systems1822
Dry Powder Formulations1845
Metered Dose Formulations1895
Transdermal Drug Delivery Systems1942
Products &Technologies1962
Developers &Suppliers1983
Applications2017
Implantable Drug Delivery Systems2082
Drug-Eluting Stents2102
Drug Inserts2122
Brachytherapy2142
APPLICATIONS21635
General2163
Central Nervous System Agents2194
Respiratory Agents2233
Hormones &Related Agents2265
Gastrointestinal Agents2312
Cardiovascular Agents2334
Anti-Infective Agents2373
Nutritional Agents2403
Biologicals2432
Genito-Urinary Agents2452
Other Therapies2474
INDUSTRY STRUCTURE25122
General2512
Developmental Revenues2534
Market Share2571
Competitive Strategies2583
Mergers &Acquisitions2612
Licensing &Related Agreements2637
Marketing &Distribution2702
Manufacturing2721
Company Profiles273104
Alkermes Incorporated2743
AptarGroup Incorporated2772
Aradigm Corporation2793
Associated British Foods plc2822
Baxter International Incorporated2846
Becton, Dickinson and Company2903
Catalent Pharma Solutions Incorporated2933
Cephalon Incorporated2964
Consort Medical plc3002
Corium International Incorporated3022
CyDex Pharmaceuticals Incorporated3042
Depomed Incorporated3062
Dow Corning Corporation3081
DURECT Corporation3094
Elan Corporation plc3135
Emisphere Technologies Incorporated3182
Eurand NV3204
Flamel Technologies SA3243
Genzyme Corporation3273
Hospira Incorporated3304
Johnson &Johnson3346
Nastech Pharmaceutical Company Incorporated3403
Nektar Therapeutics3435
Nitto Denko Corporation3483
NOF Corporation3512
Penwest Pharmaceuticals Company3532
ReAble Therapeutics Incorporated3552
Safety Syringes Incorporated3572
3M Company3594
Valeritas LLC3632
Other Companies Mentioned in Study36512

Table Of Contents

Freedonia Market Research—Reports provide industry insights targeting market size, product and market segmentation, product and market forecasts, industry composition, market leaders and business trends.

About the Author


Cite this Report

  
MLA:
Freedonia Market Research. "Drug Delivery Systems to 2012" Mar 01, 2008. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Freedonia-Market-Research/Drug-Delivery-Systems-to-2012-2039-26>
  
APA:
Freedonia Market Research. (2008). Drug Delivery Systems to 2012 Mar 01, 2008. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Freedonia-Market-Research/Drug-Delivery-Systems-to-2012-2039-26>
  
US$ 4,500.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.